Search
Calcium oxide
go.drugbank.com/drugs/DB15648InvestigationalCategories: Compounds used in a research, industrial, or household settingDodecyltrimethylammonium
go.drugbank.com/drugs/DB02779ExperimentalSynonyms: laurtrimonium ion, Dodecyltrimethylammonium ionCategories: Compounds used in a research, industrial, or household settingCoral snake (micrurus fulvius) immune globulin antivenin (equine)
go.drugbank.com/drugs/DB13883ApprovedIt is intravenously administered so that the antivenin binds to and neutralizes coral snake venom. … North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snake bites.
Indirubin
go.drugbank.com/drugs/DB12379InvestigationalIndirubin is under investigation in clinical trial NCT01735864 (Dosage Determination Trial for Indigo Naturalis Extract in Oil Ointment).
Categories: Compounds used in a research, industrial, or household settingVIR201
go.drugbank.com/drugs/DB05110Experimentalis an experimental therapeutic vaccine currently in clinical trial. The aim of therapeutic vaccines is to augment the body's immune response to HIV and to delay or prevent progression to AIDS.
Chromanol
go.drugbank.com/drugs/DB13111InvestigationalChromanol has been used in trials studying the treatment of Prostate Cancer.
Categories: Compounds used in a research, industrial, or household settingRauwolfia serpentina root
go.drugbank.com/drugs/DB09363InvestigationalRauwolfia (Rauwolfia serpentina), also spelled _ravolphia_, is a medicinal plant in the milkweed family. The root of the plant is ground into a powder or sold in tablets or capsules. … It is a compound commonly used in Asian medicine, which includes traditional Ayurvedic medicine native to India.
CX501
go.drugbank.com/drugs/DB05174InvestigationalIt is developed by Cellerix and is in phase I of clinical trials. … Cx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of
DP-b99
go.drugbank.com/drugs/DB05820InvestigationalDP-b99 is a newly developed lipophilic, cell permeable derivative of BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid), that is under development as a neuroprotectant for the potential treatment
Darifenacin
go.drugbank.com/drugs/DB00496ApprovedInvestigationalIt is unknown if M3 receptor selectivity is clinically advantageous in overactive bladder syndrome treatments. … This block reduces the urgency to urinate and so it should not be used in people with urinary retention.